Under current US law, does paid early access to market-moving posts by a sitting president constitute insider trading, market manipulation, or a legal information service?

Federal insider-trading law under Section 10(b)/Rule 10b-5 requires either a classic fiduciary breach (Chiarella v. United States) or misappropriation of confidential information obtained through a relationship of trust and confidence (Dirks v. SEC; United States v. O'Hagan). Neither applies here. Truth API does not give subscribers secret government data extracted from Trump's official duties; it delivers Trump's own voluntarily published personal statements, milliseconds before the general public sees them, exactly as TMTG spokeswoman Shannon Devine put it: Truth API offers "the fastest way to ingest publicly available Truth Social data." There is no misappropriated source, no breached duty of confidentiality, and no deception — the product was announced openly, with pricing publicly reported by CNBC and the Financial Times before its August 1 launch. As one legal analyst told NPR, Trump's lawyers can plausibly argue that because the arrangement was announced in the open, "it's not deceitful, it's not fraudulent." That is precisely the legal test insider-trading doctrine applies.

This is functionally identical to lawful latency-arbitrage products that have existed for decades. Exchanges like NASDAQ and NYSE have sold co-location and direct data-feed access to high-frequency trading firms since the mid-2000s, sometimes for millions of dollars, giving paying subscribers a microsecond-to-millisecond edge over retail investors who rely on consolidated feeds from Reuters or Bloomberg. The SEC's own market-structure concept releases have treated this as a permissible, if debated, feature of modern market design — not fraud — because everyone eventually gets the same information; only speed of receipt differs. Truth API is the same model applied to a social-media feed instead of an order book.

Second, the STOCK Act itself is instructive on scope, not prohibition. The 2012 Act affirmed that executive branch employees owe a duty of trust regarding MNPI "derived from their positions" and "gained from performance of official responsibilities" — language that targets confidential government information, not a president's own public commentary. Notably, the newly passed House "Stop Insider Trading Act" (232-198, July 2026) explicitly excludes the president and vice president from its individual-stock trading ban, leaving the president governed by disclosure requirements rather than a trading prohibition — a deliberate legislative choice, not an oversight, according to ethics lawyer Richard Painter's own characterization of the gap as one requiring new legislation, not existing enforcement.

What's at stake: if regulators stretch insider-trading doctrine to cover a public figure's own voluntary speech monetized via speed, they would criminalize a business model — selling faster access to public statements — that underlies legitimate newswire and data-feed industries worth billions of dollars, without any statutory basis for doing so.

B's strongest point is the personal-benefit/conflict-of-interest evidence: the Donald J. Trump Revocable Trust holds roughly 114.75 million DJT shares (about 41% of the company), meaning Trump personally benefits when TMTG monetizes his own posts, and ethics attorney Virginia Canter's characterization of Truth Social as a de facto "presidential press room" channeled through a business he owns is a genuine, serious ethics concern. I concede this is a real conflict of interest that ethics regulators and Congress should scrutinize — it is not a frivolous complaint.

But a conflict of interest is not the same legal category as insider trading, and B's own best precedent undercuts the securities-fraud theory. B cites Blaszczak as showing government-derived policy information can be actionable — but that entire theory was vacated. In Blaszczak II (2d Cir., Dec. 27, 2022), after the Supreme Court's Kelly remand, the government itself conceded confidential government information isn't "property" under the fraud statutes, and the court vacated the substantive fraud/conversion convictions. The one insider-trading precedent B leans on for "government information equals tradable MNPI" no longer stands for that proposition — it stands for the opposite: courts have narrowed, not expanded, criminal liability for trading on government-linked information absent classic misappropriation.

More fundamentally, Dirks' personal-benefit test and its progeny (Salman, Newman, Martoma) require a tipper to breach a fiduciary duty owed to the owner of confidential information. Trump is not a corporate insider disclosing a company's secrets to a friend; he is the originator and copyright holder of his own statements, publishing them himself, to everyone, at the same moment — merely selling faster ingestion. There is no third party whose confidentiality is being betrayed. The STOCK Act's duty-of-trust provision (15 U.S.C. §78u-1(g), Pub. L. 112-105 §9) is textually limited to information "derived from [an executive branch employee's] position" and "gained from performance of official responsibilities" — a category built for agency decisions like CMS reimbursement rates, not a president's own public rhetoric.

This is exactly why securities lawyer Robert Frenchman — who has defended clients in federal government-trading investigations — told Reuters that tiering access "does not seem fair, but yes, a tech platform can tier its distribution of information without violating federal securities laws." Multiple independent outlets (Reuters, Yahoo Finance, BigGo, TalkingPointsMemo) carried this same on-record assessment. The conflict-of-interest and ethics case against Trump is strong and worth congressional and OGE attention; the criminal/civil insider-trading case under existing 10b-5 doctrine is weak, precisely because the doctrine was built around breach of duty to an information owner, not around a person monetizing speed-of-access to their own voluntary speech.

Key claims:

• Blaszczak II (2d Cir. 2022) vacated the government-information insider-trading theory B relies on, after the DOJ itself conceded confidential agency information isn't "property" under the fraud statutes.
• The Dirks/Salman personal-benefit test requires a breach of duty owed to the owner of confidential information, which doesn't fit a scenario where the speaker is disclosing his own statements to everyone simultaneously.
• The STOCK Act's duty-of-trust language is limited to information "derived from" an official position and "gained from performance of official responsibilities," not a president's voluntary personal commentary.
• Securities lawyer Robert Frenchman, who has defended clients in federal trading investigations, stated on record that platforms can legally tier information access without violating federal securities laws.
• Trump's 41% beneficial stake in TMTG creates a legitimate conflict-of-interest and ethics concern, but conflict of interest is analytically distinct from criminal insider-trading liability under current 10b-5 doctrine.

B's strongest form: Trump is not a neutral publisher but the 41%-owner-beneficiary of TMTG, selling paying institutional clients machine-readable, millisecond-early access to his own policy-moving statements — tariff threats, Fed pressure, company-specific attacks — which functions economically like an official monetizing proximity to government power, and Senators Warren/Schiff, Reps. Torres and Craig, ethics attorney Virginia Canter, and former SEC officials Tyler Gellasch and Renée Jones have all urged the SEC to investigate on exactly this theory. That is a serious, good-faith position, not a strawman.

But existing doctrine still doesn't reach it, for reasons B hasn't rebutted. First, Reg FD — B's own closest analogue for the 'selective disclosure undermines markets' principle — by its adopting release and text applies only to an issuer's material nonpublic information 'about a company,' disclosed by 'senior officials' of that issuer to analysts; it does not cover a third party's public policy commentary. As BeInCrypto's analysis of the two Senate letters notes, Truth API 'sells policy signals, not company information,' which is precisely why Warren and Schiff had to reach for insider-trading and market-manipulation statutes 'instead' of Reg FD — an implicit concession that Reg FD's own statutory framework doesn't fit. Second, B still hasn't identified a fiduciary duty being breached: Dirks/Salman/O'Hagan liability requires a tippee receiving information in violation of a duty owed to the information's owner, and Trump owns his own statements and discloses them to everyone at once — the only variable sold is speed of ingestion, not content exclusivity. Third, no enforcement action has followed the public letters from Torres (July 21), Craig, and Warren/Schiff (July 28) despite TMTG launching Truth API on schedule August 1; SEC Chair Paul Atkins's office confirmed receipt of the letters but, as of the reporting, declined to commit to any investigation, and Cornerstone Research data shows SEC enforcement actions fell roughly 30% in FY2025 under Atkins — consistent with my claim that current regulators, applying current doctrine, see no clear violation, not merely political unwillingness to act. B is right that this is 'highly actionable' as a matter of ethics, congressional oversight, and possibly new legislation (the House Stop Insider Trading Act's presidential carve-out shows Congress itself sees a gap needing a legislative fix, not an enforcement gap needing prosecutorial creativity). But 'ethically troubling and legislatively unaddressed' is different from 'illegal under current 10b-5, STOCK Act, or Reg FD doctrine' — and that distinction is the entire question posed by this debate.